Skip to main content

Grace to Acquire Fine Chemistry Services Business of Albemarle

Press releases | February 26, 2021

Fried Frank acted as counsel to W.R. Grace & Co. (Grace) in its approximately US$570 million acquisition of the Fine Chemistry Services business (FCS) of Albemarle Corporation (Albemarle), which includes US$300 million paid in cash at closing and US$270 million funded through the issuance to Albemarle of non-participating preferred equity of a newly created Grace subsidiary. The acquisition significantly strengthens and expands Grace's existing pharmaceutical portfolio, and upon closing, Pharma & Consumer will be the largest, fastest growing and most profitable segment within Grace's Materials Technologies business.

The Fried Frank team was led by corporate partner Steven Epstein and included corporate partners Meredith L. Mackey and Caroline Sandberg; executive compensation & ERISA partner Jason R. Ertel; intellectual property and technology partner Jason L. Greenberg; tax partner Michael J. Alter; corporate special counsel David M. McDonald; corporate real estate special counsel Melissa A. Meyrowitz; environmental special counsel Mary Beth Houlihan (Phipps); corporate associates Flora Go, Asad Hussain, Ethan B. Kamer, Carolyn A. McNamara, Marie Kwon, Hannah J. Mrakovich, and Michael P. Stromquist; executive compensation & ERISA associate Samantha Steinfeld Rozell; intellectual property and technology associate Kimberly Mihovics; litigation associates Sarah M. Madigan and Jessica Senat; and tax associate Ryan L. Conley.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.